USP Drug Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level 

 Analgesics
 Anesthetics
 Anti-Addiction/Substance Abuse Treatment Agents
 Antibacterials
 Anticonvulsants
 Antidementia Agents
 Antidepressants
 Antiemetics
 Antifungals
 Antigout Agents
 Antimigraine Agents
 Antimyasthenic Agents
 Antimycobacterials
 Antineoplastics
   Alkylating Agents
   Antiandrogens
   Antiestrogens/Modifiers
   Antimetabolites
   Aromatase Inhibitors
   Immunomodulatory Agents
   Molecular Target Inhibitors
     Tagraxofusp
     Venetoclax
     Acalabrutinib
     Ibrutinib
     Pirtobrutinib
     Zanubrutinib
     Abemaciclib
     Palbociclib [DG:DG01831]
     Ribociclib [DG:DG02084]
     Afatinib [DG:DG00717]
     Dacomitinib [DG:DG01793]
     Erlotinib [DG:DG00711]
     Gefitinib
       D01977  Gefitinib (JP18/USAN/INN)
     Osimertinib
     Tazemetostat [DG:DG03020]
     Erdafitinib
     Futibatinib
     Infigratinib [DG:DG03062]
     Pemigatinib
     Glasdegib [DG:DG02912]
     Sonidegib [DG:DG01854]
     Vismodegib
     Belinostat
     Panobinostat [DG:DG01403]
     Romidepsin
     Vorinostat
     Ivosidenib
     Olutasidenib
     Enasidenib [DG:DG02837]
     Momelotinib [DG:DG01366]
     Pacritinib
     Ruxolitinib [DG:DG00719]
     Adagrasib
     Sotorasib
     Binimetinib
     Cobimetinib [DG:DG01825]
     Selumetinib [DG:DG01414]
     Capmatinib [DG:DG02081]
     Tepotinib [DG:DG03087]
     Everolimus
     Temsirolimus
     Axitinib
     Cabozantinib [DG:DG01670]
     Lenvatinib [DG:DG01362]
     Neratinib [DG:DG02303]
     Pazopanib
     Regorafenib [DG:DG00720]
     Sorafenib [DG:DG00713]
     Sunitinib [DG:DG00712]
     Tivozanib [DG:DG01375]
     Tucatinib
     Vandetanib
     Alectinib [DG:DG01625]
     Brigatinib
     Ceritinib
     Crizotinib
     Lorlatinib
     Asciminib [DG:DG03004]
     Bosutinib [DG:DG00718]
     Dasatinib [DG:DG00714]
     Imatinib [DG:DG00710]
     Nilotinib [DG:DG00716]
     Ponatinib [DG:DG00722]
     Dabrafenib [DG:DG00721]
     Encorafenib
     Trametinib [DG:DG00723]
     Vemurafenib
     Pexidartinib [DG:DG02960]
     Fedratinib [DG:DG02968]
     Gilteritinib [DG:DG01948]
     Midostaurin
     Quizartinib [DG:DG01364]
     Lapatinib [DG:DG00715]
     Pralsetinib
     Selpercatinib
     Selinexor
     Avapritinib
     Ripretinib
     Alpelisib
     Copanlisib [DG:DG01926]
     Duvelisib
     Idelalisib
     Umbralisib [DG:DG02988]
     Niraparib [DG:DG03120]
     Olaparib
     Rucaparib [DG:DG01864]
     Talazoparib [DG:DG01865]
     Bortezomib
     Ixazomib [DG:DG01269]
     Carfilzomib
     Daunorubicin [DG:DG00697]
     Doxorubicin [DG:DG00696]
     Epirubicin [DG:DG00698]
     Etoposide [DG:DG00693]
     Idarubicin [DG:DG00700]
     Irinotecan [DG:DG00726]
     Teniposide
     Topotecan [DG:DG00725]
     Valrubicin
     Entrectinib
     Larotrectinib [DG:DG02923]
   Monoclonal Antibody/Antibody-Drug Conjugate
   Retinoids
   Antineoplastic Adjuncts/Mitigators
   Antineoplastics, Other
 Anti-Obesity Agents
 Antiparasitics
 Antiparkinson Agents
 Antipsychotics
 Antispasticity Agents
 Antivirals
 Anxiolytics
 Bipolar Agents
 Blood Glucose Regulators
 Blood Products and Modifiers
 Cardiovascular Agents
 Central Nervous System Agents
 Contraceptives
 Dental and Oral Agents
 Dermatological Agents
 Electrolytes/Minerals/Metals/Vitamins
 Gastrointestinal Agents
 Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
 Genitourinary Agents
 Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
 Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
 Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
 Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
 Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
 Hormonal Agents, Suppressant (Pituitary)
 Hormonal Agents, Suppressant (Thyroid)
 Immunological Agents
 Infertility Agents
 Inflammatory Bowel Disease Agents
 Metabolic Bone Disease Agents
 Ophthalmic Agents
 Otic Agents
 Respiratory Tract/Pulmonary Agents
 Sexual Disorder Agents
 Skeletal Muscle Relaxants
 Sleep Disorder Agents

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: January 9, 2024
According to the USP Drug Classification 2024

» Japanese version